Article Data

  • Views 1727
  • Dowloads 166

Original Research

Open Access

Imbalanced salivary electrolytes, COVID-19 severity, and dysgeusia

  • Hanadi Abdullah Alwafi1
  • Soad Shaker Ali2,3
  • Sunil Babu Kotha1,4,*,
  • Layla Waleed Abuljadayel5
  • Maha Ibrahim6
  • Ibrahim Rashad Noor Elahi7
  • Hebah Abdullah Alwafi8
  • Matthew D. Finkelman9
  • Nagla A. El-Shitany10,11,*,

1Department of Preventive Dentistry, College of Dentistry, Riyadh Elm University, 11681 Riyadh, Saudi Arabia

2Department of Histology and cell biology, Faculty of Medicine, Assiut University, 71515 Assiut, Egypt

3Department of Histology, Faculty of Medicine, Merit University, 82755 Sohag, Egypt

4Department of Pediatric and Preventive Dentistry, Sharad Pawar Dental College and Hospital, Datta Meghe Institute of Medical Sciences, Sawangi (Meghe), 4420004 Maharashtra, India

5Department of Dental Public Health, Faculty of Dentistry, King Abdulaziz University, 21589 Jeddah, Saudi Arabia

6Department of Hematology, MSF for medical research and development, 22234 Jeddah, Saudi Arabia

7Consultant of Preventive Medicine and Public Health, Department of Public Health, Directorate of Health Affairs, 22230 Jeddah, Saudi Arabia

8General surgery resident, Security force hospital, 34628 Dammam, Saudi Arabia

9Division of Biostatistics and Experimental Design, Department of Public Health and Community Service, Tufts University School of Dental Medicine, Boston, Massachusetts 02111, USA

10Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, 31527 Tanta, Egypt

11Yousef Abdullatif Jameel Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, 21589 Jeddah, Saudi Arabia

DOI: 10.22514/sv.2023.005 Vol.19,Issue 4,July 2023 pp.48-57

Submitted: 04 August 2022 Accepted: 28 October 2022

Published: 08 July 2023

*Corresponding Author(s): Sunil Babu Kotha E-mail:
*Corresponding Author(s): Nagla A. El-Shitany E-mail:


Early studies of patients who progressed to severe coronavirus disease 2019 (COVID-19) reported various serum electrolyte disturbances. Hyposalivation and dysgeusia are two of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection oral symptoms. This study investigated how SARS-CoV-2 infection affects saliva volume, pH, zinc, and inorganic components (sodium, potassium, calcium). The association between these salivary properties and dysgeusia was also investigated in patients with mild and severe COVID-19. Saliva volume, pH, zinc, sodium, potassium, and calcium were measured in 142 healthy persons (control) and 158 COVID-19 patients (72 mild and 86 severe). This study showed that saliva volume, pH, zinc, sodium, potassium, and calcium levels reduced dramatically during COVID-19. Likewise, these saliva characteristics were significantly lower in severe COVID-19 individuals than in mild COVID-19 cases. In addition, there was no correlation between dysgeusia and salivary composition, volume, or pH. All salivary indicators were reduced in the COVID-19 group reporting the loss of taste and smell and the group who perceived neither. These data suggested that COVID-19 is associated with many salivary abnormalities, including hyposalivation, decreased pH, and electrolyte imbalances. These were more pronounced in severe COVID-19 cases. According to the current study, saliva characteristics could be utilized for early diagnosis, quarantine, and therapy in COVID-19 patients. As a result, the virus transmission can be stopped, and the optimum therapeutic results might be obtained. COVID-19-associated dysgeusia was unrelated to the reduction of these changes.


COVID-19; Saliva; Electrolytes; Dysgeusia; Zinc; pH; Volume; Severity

Cite and Share

Hanadi Abdullah Alwafi,Soad Shaker Ali,Sunil Babu Kotha,Layla Waleed Abuljadayel,Maha Ibrahim,Ibrahim Rashad Noor Elahi,Hebah Abdullah Alwafi,Matthew D. Finkelman,Nagla A. El-Shitany. Imbalanced salivary electrolytes, COVID-19 severity, and dysgeusia. Signa Vitae. 2023. 19(4);48-57.


[1] Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—an update on the status. Military Medical Research. 2020; 7: 1–10.

[2] World Health Organization. 2021. WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data. Available at: (Accessed: 28 December 2022).

[3] El-Shitany N, El-Hamamsy M, Alahmadi A, Eid B, Neamatallah T, Almukadi H, et al. The impact of ABO blood grouping on COVID-19 vulnerability and seriousness: a retrospective cross-sectional controlled study among the Arab community. International Journal of Environmental Research and Public Health. 2021; 18: 1–19.

[4] Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, et al. Clinical characteristics of 140 patientsinfected with SARS-CoV-2 in Wuhan, China. European Journal of Allergy & Clinical Immunology. 2020; 75: 1730–1741.

[5] Sakaguchi W, Kubota N, Shimizu T, Saruta J, Fuchida S, Kawata A, et al. Existence of SARS-CoV-2 entry molecules in the oral cavity. International Journal of Molecular Sciences. 2020; 21: 1–16.

[6] Xu H, Zhong L, Deng J, Peng J, Dan H, Zeng X, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. International Journal of Oral Science. 2020; 12: 8.

[7] Sapkota D, Søland T, Galtung H, Sand L, Giannecchini S, To K, et al. COVID-19 salivary signature: diagnostic and research opportunities. Journal of Clinical Pathology. 2021; 74: 344–349.

[8] Xu J, Li Y, Gan F, Du Y, Yao Y. Salivary glands: potential reservoirs for COVID-19 asymptomatic infection. Journal of Dental Research. 2020; 99: 989–989.

[9] Song J, Li Y, Huang X, Chen Z, Li Y, Liu C, et al. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2. Journal of Medical Virology. 2020; 92: 2556–2566.

[10] Chen L, Zhao J, Peng J, Li X, Deng X, Geng Z, et al. Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients. Cell Proliferation. 2020; 53: e12923.

[11] To KK, Tsang OT, Yip CC, Chan K, Wu T, Chan JM, et al. Consistent detection of 2019 novel coronavirus in saliva. Clinical Infectious Diseases. 2020; 71: 841–843.

[12] Pedrosa M, Sipert C, Nogueira F. Salivary glands, saliva and oral findings in COVID-19 infection. Pesquisa Brasileira em Odontopediatria e Clínica Integrada. 2020; 20: e0104.

[13] Herrera D, Serrano J, Roldán S, Sanz M. Is the oral cavity relevant in SARS-CoV-2 pandemic? Clinical Oral Investigations. 2020; 24: 2925–2930.

[14] Lozada-Nur F, Chainani-Wu N, Fortuna G, Sroussi H. Dysgeusia in COVID-19: possible mechanisms and implications. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2020; 130: 344–346.

[15] Baghizadeh Fini M. Oral saliva and COVID-19. Oral Oncology. 2020; 108: 104821.

[16] Lao WP, Imam SA, Nguyen SA. Anosmia, hyposmia, and dysgeusia as indicators for positive SARS-CoV-2 infection. World Journal of Otorhinolaryngology—Head and Neck Surgery. 2020; 6: S22–S25.

[17] Lechien J, Chiesa-Estomba C, De Siati D, Horoi M, Le Bon S, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Oto-Rhino-Laryngology. 2020; 277: 2251–2261.

[18] Yan CH, Faraji F, Prajapati DP, Boone CE, DeConde AS. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. International Forum of Allergy & Rhinology. 2020; 10: 806–813.

[19] Tong JY, Wong A, Zhu D, Fastenberg JH, Tham T. The Prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngology—Head and Neck Surgery. 2020; 163: 3–11.

[20] Henkin RI, Bradley DF. Hypogeusia corrected by Ni++ and Zn++. Life Sciences. 1970; 9: 701–709.

[21] Tsuchiya H. Oral symptoms associated with COVID-19 and their pathogenic mechanisms: a literature review. Journal of Dentistry. 2021; 9: 32.

[22] Yagi T, Asakawa A, Ueda H, Ikeda S, Miyawaki S, Inui A. The role of zinc in the treatment of taste disorders. Recent Patents on Food, Nutrition & Agriculture. 2013; 5: 44–51.

[23] Skalny A, Rink L, Ajsuvakova O, Aschner M, Gritsenko V, Alekseenko S, et al. Zinc and respiratory tract infections: perspectives for COVID-19 (Review). International Journal of Molecular Medicine. 2020; 46: 17–26.

[24] Silva Pedrosa M, Sipert CR, Nogueira FN. Altered taste in patients with COVID-19: the potential role of salivary glands. Oral Diseases. 2021; 27: 798–800.

[25] Farshidfar N, Hamedani S. Hyposalivation as a potential risk for SARS-CoV-2 infection: inhibitory role of saliva. Oral Diseases. 2021; 27: 750–751.

[26] Villa A, Connell C, Abati S. Diagnosis and management of xerostomia and hyposalivation. Therapeutics and Clinical Risk Management. 2014; 11: 45–51.

[27] Fischer U, Boulton RB, Noble AC. Physiological factors contributing to the variability of sensory assessments: relationship between salivary flow rate and temporal perception of gustatory stimuli. Food Quality and Preference. 1994; 5: 55–64.

[28] Abduljabbar T, Alhamdan RS, Al Deeb M, AlAali KA, Vohra F. Association of salivary content alteration and early ageusia symptoms in COVID-19 infections: a systematic review. European Journal of Dentistry. 2020; 14: S152–S158.

[29] Barath E, Rosner BA. Fundamentals of biostatistics. Biometrics. 1992; 48: 976.

[30] Navazesh M. Methods for collecting saliva. Annals of the New York Academy of Sciences. 1993; 694: 72–77.

[31] Navazesh M, Christensen CM. A comparison of whole mouth resting and stimulatesalivary measurement procedures. Journal of Dental Research. 1982; 61: 1158–1162.

[32] Granger DA, Fortunato CK, Beltzer EK, Virag M, Bright MA, Out D. Focus on methodology: salivary bioscience and research on adolescence: an integrated perspective. Journal of Adolescence. 2012; 35: 1081–1095.

[33] Corey-Bloom J, Fischer RS, Kim A, Snell C, Parkin GM, Granger DA, et al. Levels of interleukin-6 in saliva, but not plasma, correlate with clinical metrics in Huntington’s disease patients and healthy control subjects. International Journal of Molecular Sciences. 2020; 21: 1–12.

[34] Fourie J, Boy S. Oral mucosal ulceration—a clinician’s guide to diagnosis and treatment. South African Dental Journal. 2016; 71: 500–508.

[35] Pedrosa MS, de Paiva MHP, Oliveira LGFL, Pereira SMS, da Silva CHV, Pompeu JGF. Oral manifestations related to dengue fever: a systematic review of the literature. Australian Dental Journal. 2017; 62: 404–411.

[36] Santosh AR, Muddana K. Viral infections of oral cavity. Journal of Family Medicine and Primary Care. 2020; 9: 36.

[37] Fathi Y, Hoseini EG, Atoof F, Mottaghi R. Xerostomia (dry mouth) in patients with COVID-19: a case series. Future Virology. 2021; 16: 315–319.

[38] Fu L, Wang B, Yuan T, Chen X, Ao Y, Fitzpatrick T, et al. Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: a systematic review and meta-analysis. Journal of Infection. 2020; 80: 656–665.

[39] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020; 395: 1054–1062.

[40] Belchior Fontenele MN, Pedrosa MDS. Xerostomia and taste alterations in COVID-19. Ear, Nose & Throat Journal. 2021; 100: 186S–187S.

[41] Lozada-Nur F, Chainani-Wu N, Fortuna G, Sroussi H. Dysgeusia in COVID-19: possible mechanisms and implications. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology. 2020; 130: 344–346.

[42] Iwabuchi H, Fujibayashi T, Yamane G, Imai H, Nakao H. Relationship between hyposalivation and acute respiratory infection in dental outpatients. Gerontology. 2012; 58: 205–211.

[43] Dziedzic A, Wojtyczka R. The impact of coronavirus infectious disease 19 (COVID-19) on oral health. Oral Diseases. 2021; 27 Suppl 3: 703–706.

[44] Baharvand M, Khodadoustan A, Mohammadi M, Mortazavi H, Movah-hedian A. Xerostomia due to systemic disease: a review of 20 conditions and mechanisms. Annals of Medical and Health Sciences Research. 2014; 4: 503.

[45] Lippi G, South AM, Henry BM. Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 2020; 57: 262–265.

[46] Pan L, Mu M, Yang P, Sun Y, Wang R, Yan J, et al. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. American Journal of Gastroenterology. 2020; 115: 766–773.

[47] Sheng W, Liu W, Wang J, Chang S, Chang S. Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan. Journal of the Formosan Medical Association. 2021; 120: 311–317.

[48] Panda S, Mohamed A, Sikka K, Kanodia A, Sakthivel P, Thakar A, et al. Otolaryngologic manifestation and long-term outcome in mild COVID-19: experience from a tertiary care centre in India. Indian Journal of Otolaryngology and Head & Neck Surgery. 2021; 73: 72–77.

[49] Altin F, Cingi C, Uzun T, Bal C. Olfactory and gustatory abnormalities in COVID-19 cases. European Archives of Oto-Rhino-Laryngology. 2020; 277: 2775–2781.

[50] Cazzolla A, Lovero R, Lo Muzio L, Testa N, Schirinzi A, Palmieri G, et al. Taste and smell disorders in COVID-19 patients: role of interleukin-6. ACS Chemical Neuroscience. 2020; 11: 2774–2781.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.

Index Copernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.

Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.

Scopus: CiteScore 1.0 (2022) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.

Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.

Submission Turnaround Time